Dr. Albert Chen, MD
Claim this profileMichael E DeBakey VA Medical Center
Studies Small Cell Lung Cancer
Studies Pancreatic Cancer
2 reported clinical trials
16 drugs studied
Area of expertise
1Small Cell Lung Cancer
Stage I
Stage II
Stage IV
2Pancreatic Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Albert Chen, MD is currently running
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
Systemic + Local Therapy
for Prostate Cancer
This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic prostate cancer. Oligometastasis will be defined as 1-10 sites of metastatic disease based on the clinical determination of the LSI which incorporates all imaging, clinical, and pathologic data available.
Recruiting1 award Phase 2 & 33 criteria
More about Albert Chen, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Albert Chen, MD has experience with
- Magnetic Resonance Imaging
- Prophylactic Cranial Irradiation
- ADT + Abiraterone + Methylprednisolone
- ADT + Abiraterone + Prednisone
- ADT + Apalutamide
- ADT + Docetaxel +/- Prednisone
Breakdown of trials Albert Chen, MD has run
Small Cell Lung Cancer
Pancreatic Cancer
Prostate Cancer
Oligometastasis
Oligorecurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Albert Chen, MD specialize in?
Albert Chen, MD focuses on Small Cell Lung Cancer and Pancreatic Cancer. In particular, much of their work with Small Cell Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Albert Chen, MD currently recruiting for clinical trials?
Yes, Albert Chen, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Albert Chen, MD has studied deeply?
Yes, Albert Chen, MD has studied treatments such as Magnetic Resonance Imaging, Prophylactic Cranial Irradiation, ADT + Abiraterone + Methylprednisolone.
What is the best way to schedule an appointment with Albert Chen, MD?
Apply for one of the trials that Albert Chen, MD is conducting.
What is the office address of Albert Chen, MD?
The office of Albert Chen, MD is located at: Michael E DeBakey VA Medical Center, Houston, Texas 77030 United States. This is the address for their practice at the Michael E DeBakey VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.